Phase II trial of nemorubicin hydrocloride (nemorubicin) in combination with cisplatin (cDDP) in patients (pts) with hepatocellular carcinoma (HCC): First step results

被引：0
|
作者：
Izzo, F.
Catino, A. M.
Vogl, T. J.
Middleton, M.
Valle, J. W.
Fiore, F.
Gadaleta, C. D.
Pirotta, R. M.
Martignoni, M.
Laffranchi, B.
机构：
[1] NCI, Fdn G Pascale, Naples, Italy
[2] IRCCS Osped Oncol, Bari, Italy
[3] Hosp Johann Wolfgang Goethe Univ, Frankfurt, Germany
[4] Univ Oxford, Churchill Hosp, Oxford, England
[5] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[6] Nerviano Med Sci, Nerviano, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4593
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Nemorubicin hydrochloride (nemorubicin) in combination with cisplatin (cDDP): Phase I in patients (pts) with hepatocellular carcinoma (HCC)
    Fiore, F.
    Gadaleta, C. D.
    Granetto, C.
    Middleton, M.
    Sorio, R.
    Labianca, R.
    Valota, O.
    Pirotta, R. N.
    Battaglia, R.
    Izzo, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Phase II trial of nemorubicin hydrochloride (N) in combination with cisplatin (cDDP) administered by intra-hepatic artery (IHA) in patients (pts) with hepatocellular carcinoma (HCC): Final results.
    Izzo, Francesco
    Vogl, Thomas J.
    Gadaleta-Caldarola, Gennaro
    Middleton, Mark R.
    Valle, Juan W.
    Hammerstingl, Renate
    Gadaleta, Cosmo D.
    Martignoni, Marcella
    Petroccione, Anna
    Mariani, Mariangela
    Davite, Cristina
    Fiore, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Phase I study of nemorubicin hydrochloride (nemorubicin), a novel DNA-intercalator, in combination with cisplatin in patients with unresectable hepatocellular carcinoma (HCC)
    Izzo, Francesco
    Grosso, Maurizio
    Middleton, Marck
    Balestreri, Luca
    Labianca, Roberto
    Catino, Anna Maria
    Valota, Olga
    Laffranchi, Bernard
    Fiore, Francesco
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3380S - 3380S
  • [4] Transarterial chemotherapy (TAC) with nemorubicin and cisplatin for unresectable hepatocellular carcinoma (HCC): Preliminary report
    Fiore, Francesco
    Nasti, Guglielmo
    Izzo, Francesco
    D'Angelo, Roberto
    Facchini, Gaetano
    Pignata, Sandro
    Siani, Alfredo
    Iaffaioli, Vincenzo
    ANNALS OF ONCOLOGY, 2007, 18 : 12 - 12
  • [5] Cisplatin/epinephrine (CDDP/epi) injectable administered percutaneously for treatment of hepatocellular carcinoma (HCC): Results of a phase II clinical trial
    Geschwind, JH
    Johnson, PJ
    Yu, SC
    Vogl, TJ
    Gores, GJ
    Thuluvath, PJ
    RADIOLOGY, 2000, 217 : 172 - 172
  • [6] Extended linifanib therapy in patients (pts) with advanced hepatocellular carcinoma (HCC) in a phase II trial
    Chen, P. J.
    Yong, W.
    Carr, B. I.
    Sato, T.
    Qin, Q.
    Qian, J.
    Ansell, P. J.
    McKeegan, E. M.
    McKee, M. D.
    Ricker, J. L.
    Carlson, D. M.
    Toh, H. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Combination therapy of envafolimab and suvemcitug in patients with hepatocellular carcinoma (HCC): Results from a phase II clinical trial
    Ma, L.
    Zhang, Y.
    Fang, Y.
    Hao, C.
    Fan, Q.
    Jiang, D.
    Lu, L.
    Su, F.
    Yang, C.
    Liu, Z.
    Tian, J.
    Sun, X.
    Sun, S.
    Cheng, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S599 - S600
  • [8] Phase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC)
    Ryoo, B-Y.
    Ren, Z.
    Kim, T-Y.
    Pan, H.
    Rau, K-M.
    Choi, H. J.
    Park, J-W.
    Kim, J. H.
    Yen, C-J.
    Kim, B-H.
    Zhou, D.
    Straub, J.
    Zhao, C.
    Qin, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Phase II trial of sorafenib (S) and capecitabine (C) for hepatocellular carcinoma (HCC) in cirrhotic patients (pts).
    Rojas-Hernandez, Cristhiam Mauricio
    Patt, Yehuda Z.
    Fekrazad, M. Houman
    Steinberg, Kim A.
    Roach, Mary
    Lee, Fa-Chyi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Phase I/II study of E7050 (golvantinib) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC): Phase I results
    O'Neil, Bert H.
    Bendell, Johanna C.
    Modiano, Manuel R.
    Machiels, Jean-Pascal H.
    Versola, Melissa Jo
    Hodge, Jeff Paul
    Sawarna, Karen
    Tse, Nielson
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345